Identification of HPV DNA in patients with juvenile-onset recurrent respiratory papillomatosis using SYBR® Green real-time PCR

被引:49
作者
Draganov, P
Todorov, S
Todorov, I
Karchev, T
Kalvatchev, Z
机构
[1] Natl Ctr Infect & Paras Dis, Dept Virol, Mol Virol Lab, Sofia 1233, Bulgaria
[2] MBAL Queen Ioanna, Dept Otorhinolaryngol, Sofia 1504, Bulgaria
关键词
juvenile-onset recurrent respiratory papillomatosis; HPV;
D O I
10.1016/j.ijporl.2005.07.018
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: Recurrent respiratory papillomatosis (RRP) is the most common benign neoplasm affecting the larynx and upper respiratory tract in children. Human papillomavirus (HPV) has been implicated as the cause of RRP, most commonly types 6 and 11. The present study was undertaken to evaluate the occurrence of HPV types in a group of patients with juvenile-onset RRP (JORRP). Methods: The study group consists of 23 patients with JORRP. The clinical records of the patients were reviewed, and JORRP was classified as non-aggressive or aggressive. The laryngeal biopsies were taken and investigated for HPV DNA presence using real-time polymerase chain reaction (PCR) with a set of consensus primers (MY09/11). Viral typing was subsequently performed by real-time PCR with type-specific primers for HPV types 6, 11, 16, 18, 31, and 33. Results: HPV presence was detected in all samples with amplifiable DNA. HPV-11 was revealed in 61.9% of the patients and HPV-6 in 23.8%. Double positivity for HPV types 6 and 11 was identified in 14.3%. Our findings suggest that RRP runs a more aggressive clinical course when HPV-11 infection is present (p = 0.0265). Conclusions: Our results suggest a high frequency of HPV infection in the upper respiratory tract of the studied patients. We believe that the routine application of molecular techniques such as PCR for detection and analysis of HPVs in patients with RRP has diagnostic and prognostic significance. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:469 / 473
页数:5
相关论文
共 15 条
[1]   Latent human papillomavirus infection is comparable in the larynx and trachea [J].
Abramson, AL ;
Nouri, M ;
Mullooly, V ;
Fisch, G ;
Steinberg, BM .
JOURNAL OF MEDICAL VIROLOGY, 2004, 72 (03) :473-477
[2]   Human papillomavirus and cervical cancer [J].
Burd, EM .
CLINICAL MICROBIOLOGY REVIEWS, 2003, 16 (01) :1-+
[3]  
Cubie HA, 2001, J CLIN PATHOL-MOL PA, V54, P24, DOI 10.1136/mp.54.1.24
[4]   HUMAN PAPILLOMAVIRUS-6, PAPILLOMAVIRUS-11, AND PAPILLOMAVIRUS-16 IN LARYNGEAL PAPILLOMAS [J].
DICKENS, P ;
SRIVASTAVA, G ;
LOKE, SL ;
LARKIN, S .
JOURNAL OF PATHOLOGY, 1991, 165 (03) :243-246
[5]   RECURRENT RESPIRATORY PAPILLOMATOSIS - JUVENILE VERSUS ADULT FORMS [J].
DOYLE, DJ ;
GIANOLI, GJ ;
ESPINOLA, T ;
MILLER, RH .
LARYNGOSCOPE, 1994, 104 (05) :523-527
[6]   Human papillomavirus and west variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis [J].
Gabbott, M ;
Cossart, YE ;
Kan, A ;
Konopka, M ;
Chan, R ;
Rose, BR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (12) :3098-3103
[7]   2′,5′-oligoadenylate synthetase activity analysis and human papilloma virus typing as prognostic factors in patients with recurrent respiratory papillomatosis [J].
Gerein, V ;
Rastorguev, E ;
Gerein, J ;
Lodemann, E ;
Pfister, H ;
Draf, W ;
Desloovere, C .
JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2004, 118 (10) :750-756
[8]  
KALVATCHEV Z, 2003, BIOTECHNOL BIOTECHNO, V17, P146
[9]  
Lele SM, 2002, ARCH PATHOL LAB MED, V126, P1184
[10]  
Long Yeoh T, 2003, Asian J Surg, V26, P112, DOI 10.1016/S1015-9584(09)60231-1